MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
Chen J, Guanizo AC, Jakasekara WSN, Inampudi C, Luong Q, Garama DJ, Alamgeer M, Thakur N, DeVeer M, Ganju V, Watkins DN, Cain JE, Gough DJ.
Chen J, et al.
J Exp Clin Cancer Res. 2023 Apr 26;42(1):100. doi: 10.1186/s13046-023-02678-1.
J Exp Clin Cancer Res. 2023.
PMID: 37098540
Free PMC article.